Jain PharmaBiotech, Feb 2012, Pages: 864
of multiple sclerosis
Myelin imaging by PET
Biomarkers of response to therapy of multiple sclerosis
DNA motifs in the blood as biomarkers of response to treatment
Concluding remarks and future perspective
Life Science Intelligence, Inc., July 2007
bone
Company 243 - Drug product for the treatment of acute spinal cord injury, cancer, macular degeneration, and glaucoma
Company 244 - Nitric oxide-based therapies to accelerate healing of tendon, bone